Articles
5Y News｜Neox Biotech Completes $30 Million Series A Round, 5Y Capital Continues Support
Exploring the most cutting-edge drug modalities.
Hyperparameter Closes $30 Million Series A+ Round to Accelerate Game AI Expansion
Dedicated to transforming how game content is produced through artificial intelligence.
5Y News | 5Y Capital portfolio company Superparameter Technology completes $30 million Series A+ round
Transforming game content production through AI.
Galixir's Chengtao Li: Finding the "Key" to Curing Disease with AI in the Universe of Compounds | Rong Talk --- In the vast "universe" of chemical compounds, finding the molecule that can precisely target a disease is like searching for a needle in a haystack — except the haystack contains more stars than there are in the Milky Way. This is where Galixir comes in. Founded in 2019, Galixir is an AI-driven drug discovery company that uses artificial intelligence to navigate the astronomical complexity of molecular space. At its helm is Chengtao Li, a Tsinghua University PhD who spent years at MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) before returning to China to build what he calls "a new kind of pharmaceutical R&D engine." "The traditional drug discovery process is incredibly inefficient," Li tells us in a wide-ranging conversation at the company's Beijing headquarters. "You're talking about 10 to 15 years and $2-3 billion to bring a single drug to market. And the failure rate is brutal. We think AI can fundamentally change that equation." Galixir's approach centers on what Li describes as "generative chemistry" — using deep learning models to design novel molecules from scratch, rather than merely screening existing compound libraries
How artificial intelligence technology is accelerating drug discovery and development.
5Y View | Xiaoxiao Zhou, 5Y Capital: The Underlying Logic of Business Is Supply and Demand
Companies that can truly close the loop on supply-demand dynamics are the ones that change the world — but they are few and far between.
5Y News | Xinhuazhang, a 5Y Capital portfolio company, announces completion of Series A+ round
Accelerating the R&D push for EDA 2.0, with continued backing from 5Y Capital.
Xinhuazhang, an EDA company, announced the completion of its Series A+ funding round to accelerate R&D progress on EDA 2.0.
Building EDA 2.0 technology for a digital society, defining an intelligent future from the chip up.
5Y News | Men's Grooming Brand "理然" Closes Nearly RMB 150 Million Series B Round
The next generation of male consumers is continuously evolving in their grooming and personal-image needs.
5Y News | 5Y Capital Portfolio Company StartDT (奇点云) Closes RMB 80 Million B2 Round
Openness and mutual success: building a new cloud-based, data-intelligent business together.
Shexu Technology Raises Tens of Millions of RMB in Angel Round to Build Industrial Intelligent Design and Manufacturing Cloud Platform
AI + SaaS, making industrial design smarter.